Karen Visser

Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: A double‐blind, randomized, placebo‐controlled trial

Henrike van Dongen, Jill van Aken, Leroy R. Lard et al. · Arthritis & Rheumatism · 2007 · 410 citations

EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors

Marie Kostine, Axel Finckh, Clifton O. Bingham et al. · Annals of the Rheumatic Diseases · 2020 · 258 citations · Full text

Intervention with methotrexate in patients with arthralgia at risk of rheumatoid arthritis to reduce the development of persistent arthritis and its disease burden (TREAT EARLIER): a randomised, double-blind, placebo-controlled, proof-of-concept trial

Doortje I Krijbolder, Marloes Verstappen, Bastiaan T van Dijk et al. · The Lancet · 2022 · 163 citations · Full text

Rheumatoid Disorder, Rheumatology, Proof-of-concept Trial +7

Remission induction therapy with methotrexate and prednisone in patients with early rheumatoid and undifferentiated arthritis (the IMPROVED study)

K. Wevers-de Boer, Karen Visser, L. Heimans et al. · Annals of the Rheumatic Diseases · 2012 · 101 citations

Intermittent Claudication: Cost-effectiveness of Revascularization versus Exercise Therapy

Sybolt O. de Vries, Karen Visser, Jelle A. de Vries et al. · Radiology · 2002 · 86 citations